Representative Thomas Massie (R-KY) Speaking at C4IP Launch Reception
Representative Thomas Massie (R-KY) Speaking at C4IP Launch Reception Read More »
First House office will hold union vote today
On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
First House office will hold union vote today Read More »
IP Leaders Join Forces to Counter Anti-IP Narratives
On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
IP Leaders Join Forces to Counter Anti-IP Narratives Read More »
IP Luminaries Launch Group To Promote, Defend Innovation
On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
IP Luminaries Launch Group To Promote, Defend Innovation Read More »
It’s time to support today’s Edisons
Not since the days of Thomas Edison — the prolific innovator who patented the incandescent lightbulb and a record 1,092 other breakthroughs — have inventors received so much praise. TIME named the scientists who developed the mRNA platform behind the leading Covid-19 vaccines — Kizzmekia Corbett, Barney Graham, Katalin Kariko and Drew Weissman — “Heroes
It’s time to support today’s Edisons Read More »
Ex-patent officials, U.S. judges join lobbyist for IP policy push
On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
Ex-patent officials, U.S. judges join lobbyist for IP policy push Read More »
Former USPTO Directors Launch Bipartisan Advocacy Organization Dedicated to Promoting and Defending U.S. Innovation
WASHINGTON (September 22, 2022) — Today, the Council for Innovation Promotion, a new coalition that will advocate for the preservation of U.S. intellectual property, formally launched. “Our Founding Fathers enshrined intellectual property rights in the U.S. Constitution for good reason,” said Andrei Iancu, co-chair of C4IP’s board of directors and former Under Secretary of Commerce
The Law is Clear: There’s No Legal Authority to Control Prices Via Bayh-Dole
On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional
The Law is Clear: There’s No Legal Authority to Control Prices Via Bayh-Dole Read More »